| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |